|
Market Cap (5-Jul) $8,036,723,200 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 54.95 |
EPS 0.14 |
TLX released this announcement to the ASX on 8 February 2021, 8:26. The announcement is not marked as price sensitive, and is 2 page(s) in length and 214.02kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.009% short sold according to ASIC data. It was ranked the 559th most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Telix Pursues Direct Benelux Product Distribution | 8 February 2021, 8:26 |
| Appendix 3G - issue of unlisted share options | 29 January 2021, 8:49 |
| Appendix 4C and Activities Report for December 2020 Quarter | 29 January 2021, 8:43 |
| First US patients dosed in Ph III ZIRCON trial | 25 January 2021, 9:02 |
You must be logged in to post a reply.
Telix Pharmaceuticals 